Search

Home > OIS Podcast > Novaliq’s Positive Phase II Dry Eye Results Present Break from Disappointing Clinical Trial Season
Podcast: OIS Podcast
Episode:

Novaliq’s Positive Phase II Dry Eye Results Present Break from Disappointing Clinical Trial Season
Category: Business
Duration: 00:24:11
Publish Date: 2017-01-11 23:00:00
Description: Christian Roesky, PhD, joins the OIS Podcast to explain why he became the new CEO and managing director of Novaliq GmbH, a specialty pharma company with a novel drug delivery platform technology that can make drugs more effective in treating ophthalmic disorders. He also delves into the company’s positive Phase II evaluating CyclASol in 207 patients with moderate-to-severe dry eye disease.
Total Play: 0